{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:35:26Z","timestamp":1760297726631},"reference-count":83,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.mcna.2006.07.002","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T14:28:20Z","timestamp":1168439300000},"page":"1125-1140","source":"Crossref","is-referenced-by-count":7,"title":["Antibiotic Therapy for\u00a0Helicobacter\u00a0pylori"],"prefix":"10.1016","volume":"90","author":[{"given":"Jason","family":"Collins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira","family":"Ali-Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duane T.","family":"Smoot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2006.07.002_bib1","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(84)91816-6","article-title":"Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration","volume":"16","author":"Marshall","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2006.07.002_bib2","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1128\/CMR.10.4.720","article-title":"Helicobacter pylori","volume":"10","author":"Dunn","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.mcna.2006.07.002_bib3","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1111\/j.1572-0241.2001.04104.x","article-title":"The importance of vacA, cagA, and iceA genotypes of Helicobacter pylori infection in peptic ulcer disease and gastroesophageal reflux disease","volume":"96","author":"Arents","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mcna.2006.07.002_bib4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1523-5378.2005.00339.x","article-title":"Pathogenesis of Helicobacter pylori infection","volume":"10","author":"Figueiredo","year":"2005","journal-title":"Helicobacter"},{"key":"10.1016\/j.mcna.2006.07.002_bib5","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nrmicro1095","article-title":"Helicobacter pylori VacA, a paradigm for toxin multifunctionality","volume":"3","author":"Cover","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.mcna.2006.07.002_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2036.2002.0160s1003.x","article-title":"Review article: natural history and epidemiology of Helicobacter pylori infection","volume":"16","author":"Go","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mcna.2006.07.002_bib7","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/0140-6736(91)93196-G","article-title":"Water source as risk factor for Helicobacter pylori infection in Peruvian children","volume":"337","author":"Klein","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2006.07.002_bib8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1067\/mps.2001.118485","article-title":"Helicobacter pylori infection in children","volume":"31","author":"Gold","year":"2001","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"10.1016\/j.mcna.2006.07.002_bib9","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1056\/NEJM198912073212302","article-title":"Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons","volume":"321","author":"Dooley","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2006.07.002_bib10","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1086\/315384","article-title":"Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States","volume":"18","author":"Everhart","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mcna.2006.07.002_bib11","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1128\/CDLI.7.6.885-888.2000","article-title":"High prevalence of Helicobacter pylori in the Alaska Native population and association with low serum ferritin levels in young adults","volume":"7","author":"Parkinson","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.mcna.2006.07.002_bib12","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/0140-6736(92)92894-L","article-title":"Isolation of Helicobacter pylori from human faeces","volume":"340","author":"Thomas","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2006.07.002_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1099\/0022-1317-49-4-343","article-title":"Quantitative culture of Helicobacter pylori from gastric juice: the potential for transmission","volume":"49","author":"Young","year":"2000","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.mcna.2006.07.002_bib14","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1001\/jama.282.23.2240","article-title":"Fecal and oral shedding of Helicobacter pylori from healthy infected adults","volume":"282","author":"Parsonnet","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2006.07.002_bib15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/gut.52.2.186","article-title":"Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults","volume":"52","author":"Rosenstock","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.mcna.2006.07.002_bib16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3748\/wjg.v11.i1.104","article-title":"Eradication of Helicobacter pylori significantly reduced gastric damage in nonsteroidal anti-inflammatory drug\u2013treated Mongolian gerbils","volume":"11","author":"Chang","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.mcna.2006.07.002_bib17","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1365-2036.2004.02246.x","article-title":"Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin\/non-steroidal anti-inflammatory drugs","volume":"20","author":"Pilotto","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mcna.2006.07.002_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003840.pub4","article-title":"Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients","volume":"2","author":"Ford","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mcna.2006.07.002_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002096.pub4","article-title":"Eradication of Helicobacter pylori for non-ulcer dyspepsia","volume":"2","author":"Moayyedi","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mcna.2006.07.002_bib20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2036.2002.01169.x","article-title":"Current concepts in the management of Helicobacter pylori infection\u2014the Maastricht 2-2000 Consensus Report","volume":"16","author":"Malfertheiner","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.mcna.2006.07.002_bib21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1365-2036.2003.01665.x","article-title":"Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease","volume":"18","author":"Cremonini","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mcna.2006.07.002_bib22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/bmj.326.7392.737","article-title":"Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systemic review","volume":"326","author":"Raghunath","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.mcna.2006.07.002_bib23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1365-2036.2003.01428.x","article-title":"Review article: Helicobacter pylori and reflux disease","volume":"17","author":"Sharma","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.mcna.2006.07.002_bib24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2036.2004.02172.x","article-title":"Systematic review: the effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis","volume":"20","author":"Raghunath","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mcna.2006.07.002_bib25","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1086\/430353","article-title":"Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii","volume":"191","author":"Nomura","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mcna.2006.07.002_bib26","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1056\/NEJM199110173251603","article-title":"Helicobacter pylori infection and the risk of gastric carcinoma","volume":"325","author":"Parsonnet","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2006.07.002_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.291.2.187","article-title":"Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial","volume":"291","author":"Wong","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2006.07.002_bib28","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/path.1593","article-title":"Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma in an animal model of Helicobacter heilmannii infection","volume":"203","author":"O'Rourke","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.mcna.2006.07.002_bib29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gut.53.1.34","article-title":"Long-term outcome of patients with gastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series","volume":"53","author":"Fischbach","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.mcna.2006.07.002_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/00365520510023873","article-title":"Cost-effectiveness of Helicobacter pylori \u201ctest and treat\u201d for patients with typical reflux symptoms in a population with a high prevalence of H. pylori infection: a Markov model analysis","volume":"41","author":"You","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.mcna.2006.07.002_bib31","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/archinte.163.10.1165","article-title":"A randomized controlled trial of test-and-treat strategy for Helicobacter pylori: clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease","volume":"163","author":"Allison","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.mcna.2006.07.002_bib32","first-page":"1138","article-title":"Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysis","volume":"91","author":"Loy","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mcna.2006.07.002_bib33","first-page":"233","article-title":"Microdose 14C-urea breath test offers diagnosis of Helicobacter pylori in 10 minutes","volume":"91","author":"Peura","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mcna.2006.07.002_bib34","first-page":"224","article-title":"[13C] urea breath test to confirm eradication of Helicobacter pylori","volume":"90","author":"Slomianski","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mcna.2006.07.002_bib35","doi-asserted-by":"crossref","unstructured":"Vaira D, Malfertheiner P, Megraud F, et al and the HpSA European study group. Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. Lancet 1999;354:30\u20133.","DOI":"10.1016\/S0140-6736(98)08103-3"},{"key":"10.1016\/j.mcna.2006.07.002_bib36","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0016-5085(95)90278-3","article-title":"Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection","volume":"109","author":"Cutler","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mcna.2006.07.002_bib37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jcp.49.2.107","article-title":"Detection of Helicobacter pylori in gastric biopsy and resection specimens","volume":"49","author":"Aston-Key","year":"1996","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.mcna.2006.07.002_bib38","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0016-5107(97)70174-3","article-title":"Prospective comparison of H&E, Giemsa and Genta stains for the diagnosis of Helicobacter pylori","volume":"45","author":"Laine","year":"1997","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.mcna.2006.07.002_bib39","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/jcp.53.10.756","article-title":"Histological identification of Helicobacter pylori: comparison of staining methods","volume":"53","author":"Rotimi","year":"2000","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.mcna.2006.07.002_bib40","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0889-8553(05)70154-0","article-title":"Accurate diagnosis of Helicobacter pylori. Urease test","volume":"29","author":"Midolo","year":"2000","journal-title":"Gastroenterol Clin North Am"},{"issue":"11","key":"10.1016\/j.mcna.2006.07.002_bib41","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1097\/00042737-199911000-00012","article-title":"Reliability of biopsy-based diagnostic tests for Helicobacter pylori after treatment aimed at its eradication","volume":"11","author":"van der Wouden","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2006.07.002_bib42","first-page":"202","article-title":"Diagnostic tests for Helicobacter pylori infection","volume":"5","author":"Cutler","year":"1997","journal-title":"Gastroenterologist"},{"issue":"15","key":"10.1016\/j.mcna.2006.07.002_bib43","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJMra020542","article-title":"Helicobacter pylori infection","volume":"347","author":"Suerbaum","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2006.07.002_bib44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00045391-199805000-00011","article-title":"Treatment of Helicobacter pylori","volume":"5","author":"Vakil","year":"1998","journal-title":"Am J Ther"},{"key":"10.1016\/j.mcna.2006.07.002_bib45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.272.1.65","article-title":"National Institutes of Health Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in peptic ulcer disease","volume":"272","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2006.07.002_bib46","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1111\/j.1572-0241.1998.00684.x","article-title":"Guidelines for the management of Helicobacter pylori infection","volume":"93","author":"Howden","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mcna.2006.07.002_bib47","first-page":"S3","article-title":"Key points from the revised Maastricht Consensus Report: the impact on general practice","volume":"13","author":"Bazzoli","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2006.07.002_bib48","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/j.1572-0241.1998.00602.x","article-title":"Twice daily 10 day triple therapy with esomeprazole, amoxicillin and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double blind, United States trials","volume":"93","author":"Laine","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mcna.2006.07.002_bib49","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1523-5378.1996.tb00027.x","article-title":"Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study","volume":"1","author":"Lind","year":"1996","journal-title":"Helicobacter"},{"key":"10.1016\/j.mcna.2006.07.002_bib50","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0016-5085(99)70119-8","article-title":"The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies","volume":"116","author":"Lind","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mcna.2006.07.002_bib51","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1365-2036.1999.00535.x","article-title":"The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer","volume":"13","author":"Malfertheiner","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mcna.2006.07.002_bib52","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1046\/j.1365-2036.1999.00471.x","article-title":"The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy","volume":"13","author":"Zanten","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mcna.2006.07.002_bib53","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1001\/archinte.158.15.1651","article-title":"A comparison therapy of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori","volume":"158","author":"Fennerty","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.mcna.2006.07.002_bib54","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1523-5378.2003.00179.x","volume":"8","author":"Bochenek","year":"2003","journal-title":"Helicobacter"},{"key":"10.1016\/j.mcna.2006.07.002_bib55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2036.2004.02029.x","article-title":"Seven-day therapy for Helicobacter pylori in the United States","volume":"20","author":"Vakil","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mcna.2006.07.002_bib56","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1111\/j.1572-0241.2000.03349.x","article-title":"Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials","volume":"95","author":"Laine","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mcna.2006.07.002_bib57","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1046\/j.1365-2036.1999.00542.x","article-title":"Evaluation of treatment regimens to cure Helicobacter pylori infection\u2014a meta-analysis","volume":"13","author":"Laheij","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mcna.2006.07.002_bib58","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2165\/00003495-199957060-00006","article-title":"A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy","volume":"57","author":"Peitz","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.mcna.2006.07.002_bib59","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1365-2036.2000.00744.x","article-title":"A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxicillin for treating Helicobacter pylori infection","volume":"14","author":"Calvet","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mcna.2006.07.002_bib60","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1001\/archinte.159.14.1562","article-title":"Effectiveness of Helicobacter pylori therapies in a clinical practice setting","volume":"159","author":"Fennerty","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.mcna.2006.07.002_bib61","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1111\/j.1572-0241.2000.03174.x","article-title":"Latin-American Consensus Conference on Helicobacter pylori infection","volume":"95","author":"Coelho","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mcna.2006.07.002_bib62","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1046\/j.1365-2036.2003.t01-1-01712.x","article-title":"Triple vs. quadruple therapy for treating Helicobacter pylori infection: an updated meta analysis","volume":"18","author":"Gene","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mcna.2006.07.002_bib63","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1046\/j.1365-2036.1997.00219.x","article-title":"Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection","volume":"11","author":"Graham","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mcna.2006.07.002_bib64","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1572-0241.2003.t01-1-07288.x","volume":"98","author":"Laine","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mcna.2006.07.002_bib65","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1046\/j.1365-2036.2000.00770.x","article-title":"Metronidazole containing quadruple therapy for infection with metronidazole resistance Helicobacter pylori: a prospective study","volume":"14","author":"Graham","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mcna.2006.07.002_bib66","first-page":"58","article-title":"Randomized study of two \u201crescue\u201d therapies for Helicobacter pylori\u2013infected patients after failure of standard triple therapies","volume":"96","author":"Perri","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mcna.2006.07.002_bib67","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1523-5378.2005.00324.x","article-title":"Review article: Helicobacter pylori \u201crescue\u201d therapy after failure of two eradication treatments","volume":"10","author":"Gisbert","year":"2005","journal-title":"Helicobacter"},{"key":"10.1016\/j.mcna.2006.07.002_bib68","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00004836-200010000-00007","article-title":"Rifabutin-based triple therapy after failure of Helicobacter pylori eradication treatment: preliminary experience","volume":"31","author":"Bock","year":"2000","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.mcna.2006.07.002_bib69","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1365-2036.2001.00909.x","article-title":"Rifabutin-based Helicobacter pylori eradication rescue therapy","volume":"15","author":"Canducci","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mcna.2006.07.002_bib70","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1046\/j.1365-2036.2001.01002.x","article-title":"Ranitidine bismuth citrate\u2013based triple therapies after failure of the standard \u201cMaastricht triple therapy\u201d: a promising alternative to the quadruple therapy?","volume":"15","author":"Perri","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mcna.2006.07.002_bib71","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1572-0241.2002.05600.x","article-title":"Colloidal bismuth subcitrate\u2013based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection","volume":"97","author":"Dore","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mcna.2006.07.002_bib72","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7326\/0003-4819-136-1-200201010-00008","article-title":"Risk factors for Helicobacter pylori resistance in the United States: the Surveillance of H. pylori Antimicrobial Resistance Partnership (SHARP) study, 1993\u20131999","volume":"136","author":"Meyer","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2006.07.002_bib73","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1365-2036.2003.01459.x","article-title":"Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second line treatment for Helicobacter pylori infection","volume":"17","author":"Wong","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mcna.2006.07.002_bib74","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1572-0241.2006.00457.x","article-title":"The H. pylori Study Group of the Asociaci\u00f3n Espa\u00f1ola de Gastroenterolog\u00eda. Third-line rescue therapy with levofloxacin after two H. pylori treatment failures","volume":"101","author":"Gisbert","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mcna.2006.07.002_bib75","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2036.2005.02522.x","article-title":"A 10 day levofloxacin-based triple therapy in patients who failed two eradication courses","volume":"22","author":"Gatta","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mcna.2006.07.002_bib76","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1523-5378.2003.00158.x","article-title":"A prospective, randomized study of quadruple therapy and high dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin","volume":"8","author":"Miehlke","year":"2003","journal-title":"Helicobacter"},{"key":"10.1016\/j.mcna.2006.07.002_bib77","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1046\/j.1365-2036.2002.01299.x","article-title":"Furazolidone-based triple \u201crescue\u201d therapy vs. quadruple \u201crescue therapy\u201d for the eradication of Helicobacter pylori resistant to metronidazole","volume":"16","author":"Isakov","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mcna.2006.07.002_bib78","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1523-5378.2002.00087.x","article-title":"Impact of furazolidone-based quadruple therapy for eradication of Helicobacter pylori after previous treatment failure","volume":"7","author":"Treiber","year":"2002","journal-title":"Helicobacter"},{"key":"10.1016\/j.mcna.2006.07.002_bib79","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1365-2036.2005.02687.x","article-title":"Helicobacter pylori first line and rescue options in patients allergic to penicillin","volume":"22","author":"Gisbert","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mcna.2006.07.002_bib80","series-title":"Helicobacter pylori: physiology and genetics","first-page":"511","article-title":"Antibiotic susceptibility and resistance","author":"M\u00e9graud","year":"2001"},{"key":"10.1016\/j.mcna.2006.07.002_bib81","first-page":"505","article-title":"Patient factors affecting H. pylori eradication with triple therapy","volume":"88","author":"Cutler","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mcna.2006.07.002_bib82","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0016-5085(99)70063-6","article-title":"Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori\u2013infected adults","volume":"116","author":"Michetti","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mcna.2006.07.002_bib83","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0889-8553(05)70137-0","article-title":"Immunology of Helicobacter pylori and prospects for vaccine","volume":"29","author":"Blanchard","year":"2000","journal-title":"Gastroenterol Clin North Am"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712506000824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712506000824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T17:40:24Z","timestamp":1587318024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712506000824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":83,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0025712506000824"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2006.07.002","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}